Logo do repositório
 
Publicação

Individual variation in Plasmodium vivax malaria risk

dc.contributor.authorCorder, Rodrigo M
dc.contributor.authorArez, Ana Paula
dc.contributor.authorFerreira, Marcelo U
dc.contributor.institutionGlobal Health and Tropical Medicine (GHTM)
dc.contributor.institutionVector borne diseases and pathogens (VBD)
dc.contributor.institutionInstituto de Higiene e Medicina Tropical (IHMT)
dc.contributor.institutionIndividual Health Care (IHC)
dc.contributor.pblPLOS - Public Library of Science
dc.date.accessioned2023-02-14T22:21:01Z
dc.date.available2023-02-14T22:21:01Z
dc.date.issued2023-01
dc.descriptionCopyright: © 2023 Corder et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.description.abstractExtensive research has examined why some people have frequent Plasmodium falciparum malaria episodes in sub-Saharan Africa while others remain free of disease most of the time. In contrast, malaria risk heterogeneity remains little studied in regions where P. vivax is the dominant species. Are repeatedly infected people in vivax malaria settings such as the Amazon just unlucky? Here, we briefly review evidence that human genetic polymorphism and acquired immunity after repeated exposure to parasites can modulate the risk of P. vivax infection and disease in predictable ways. One-fifth of the hosts account for 80% or more of the community-wide vivax malaria burden and contribute disproportionally to onward transmission, representing a priority target of more intensive interventions to achieve malaria elimination. Importantly, high-risk individuals eventually develop clinical immunity, even in areas with very low or residual malaria transmission, and may constitute a large but silent parasite reservoir.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent1261000
dc.identifier.doi10.1371/journal.pntd.0011020
dc.identifier.issn1935-2727
dc.identifier.otherPURE: 50788454
dc.identifier.otherPURE UUID: f06045b0-fe4f-4e53-bea7-2a5eab32ea8b
dc.identifier.otherPubMed: 36634044
dc.identifier.otherPubMedCentral: PMC9836309
dc.identifier.otherPubMed: 36634044
dc.identifier.otherScopus: 85146364250
dc.identifier.urihttp://hdl.handle.net/10362/149209
dc.language.isoeng
dc.peerreviewedyes
dc.subjectHumans
dc.subjectMalaria, Vivax/parasitology
dc.subjectPlasmodium vivax/genetics
dc.subjectPlasmodium falciparum/genetics
dc.subjectPrevalence
dc.subjectMalaria, Falciparum/parasitology
dc.subjectMalaria
dc.subjectRA0421 Public health. Hygiene. Preventive Medicine
dc.subjectQR Microbiology
dc.subjectInfectious Diseases
dc.subjectImmunology
dc.subjectParasitology
dc.subjectSDG 3 - Good Health and Well-being
dc.titleIndividual variation in Plasmodium vivax malaria risken
dc.title.subtitleAre repeatedly infected people just unlucky?en
dc.typereview
degois.publication.firstPage
degois.publication.issue1
degois.publication.lastPage
degois.publication.titlePLoS Neglected Tropical Diseases
degois.publication.volume17
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Individual_variation_in_Plasmodium_vivax.pdf
Tamanho:
1.2 MB
Formato:
Adobe Portable Document Format